Shareholder Alert: The Ademi Firm investigates whether Performant Healthcare Inc. is obtaining a Fair Price for its Public Shareholders

Core Viewpoint - The Ademi Firm is investigating Performant for potential breaches of fiduciary duty and other legal violations related to its transaction with Machinify, which involves a cash payment to shareholders [1][3]. Transaction Details - Shareholders of Performant will receive $7.75 in cash for each share of common stock, totaling approximately $670 million [2]. - Performant insiders are set to receive significant benefits as part of the change of control arrangements [2]. Investigation Focus - The transaction agreement imposes a substantial penalty on Performant if it accepts a competing bid, which may limit competing transactions unreasonably [3]. - The investigation will assess whether the Performant board of directors is fulfilling their fiduciary duties to all shareholders [3].